MONAS

Montelukast

RESPIRATORY » ANTI-ASTHMATIC » ANTI-INFLAMMATORY

INDICATION

Monas in indicated for the prophylaxis and chronic treatment of Asthma & for the symptomatic relief of Allergic Rhinitis.

DOSAGE AND ADMINISTRATION

Age	Dose
6 months– 6 years	4 mg/day, in the evening
6 years– 15 years	5 mg/day, in the evening
15 years and older	10 mg/day, in the evening

COMPOSITION

Monas ^® 10: Each film coated tablet contains Montelukast Sodium USP equivalent to 10 mg Montelukast.

Monas ^® 5 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ^® 4 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.

Monas ^® 5: Each Chewable tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ^® 4: Each Chewable tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.